Technical Advisor (patents)
Norton Rose Fulbright Canada LLP
Related services and key industries
During his formal training, Prateep Pakavathkumar specialized in drug discovery. He received his PhD in neuroscience while investigating novel treatment options to combat Alzheimer's disease. His post-doctoral training focused on harnessing simple model organisms to repurpose FDA-approved drugs for the treatment of amyotrophic lateral sclerosis. Dr. Pakavathkumar received scholarships from FRQS, Alzheimer Society of Canada, and ALS Canada.